Head-To-Head Survey: Precision Optics (POCI) and Its Peers

Precision Optics (NASDAQ:POCI) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Precision Optics to similar businesses based on the strength of its valuation, risk, earnings, profitability, dividends, institutional ownership and analyst recommendations.

Profitability

This table compares Precision Optics and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precision Optics	-11.51%	-23.92%	-13.05%
Precision Optics Competitors	-278.24%	-150.08%	-21.87%

Risk and Volatility

Precision Optics has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Precision Optics’ competitors have a beta of 2.56, suggesting that their average share price is 156% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Precision Optics and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1	0	0	0	1.00
Precision Optics Competitors	4273	10549	18323	829	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.34%. Given Precision Optics’ competitors stronger consensus rating and higher possible upside, analysts clearly believe Precision Optics has less favorable growth aspects than its competitors.

Insider & Institutional Ownership

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.4% of Precision Optics shares are owned by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Precision Optics and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Precision Optics	$31.53 million	-$3.63 million	-10.63
Precision Optics Competitors	$1.88 billion	$139.14 million	9.47

Precision Optics’ competitors have higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Precision Optics competitors beat Precision Optics on 10 of the 13 factors compared.

About Precision Optics

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.